Searching across hundreds of databases
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_2893933
Proper Citation: (Leinco Technologies Cat# LT1905, RRID:AB_2893933)
Target Antigen: SARS-CoV-2 RBD
Clonality: recombinant monoclonal
Comments:
Applications: ELISA, IHC
Info: Anti-SARS-CoV-2 Spike RBD-Biotin, clone 2165, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD).
We found {{ ctrl2.mentions.total_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
Check
for all resource mentions.
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Anti-SARS-CoV-2 Spike RBD (Clone 2165) - Biotin.
No alerts have been found for Anti-SARS-CoV-2 Spike RBD (Clone 2165) - Biotin.
Source: Antibody Registry
